Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) National Security (17)
- (-) Nuclear Science and Technology (6)
- Advanced Manufacturing (7)
- Biology and Environment (18)
- Clean Energy (58)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (4)
- Fusion and Fission (9)
- Fusion Energy (3)
- Isotopes (7)
- Materials (42)
- Materials for Computing (5)
- Neutron Science (14)
- Quantum information Science (1)
- Supercomputing (42)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (3)
- (-) Artificial Intelligence (6)
- (-) Computer Science (9)
- (-) Cybersecurity (9)
- (-) Energy Storage (1)
- (-) Fusion (2)
- (-) Isotopes (2)
- Advanced Reactors (3)
- Bioenergy (2)
- Biology (2)
- Biomedical (2)
- Chemical Sciences (2)
- Climate Change (1)
- Decarbonization (1)
- Environment (1)
- Exascale Computing (1)
- Frontier (1)
- Grid (1)
- High-Performance Computing (1)
- Machine Learning (4)
- Materials (1)
- Materials Science (2)
- National Security (11)
- Neutron Science (3)
- Nuclear Energy (9)
- Partnerships (4)
- Physics (2)
- Security (5)
- Space Exploration (2)
- Sustainable Energy (2)
- Transformational Challenge Reactor (1)
- Transportation (1)
Media Contacts
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.